Mangoceuticals (MGRX) Free Cash Flow (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Free Cash Flow data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 42.35% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$4.9 million (up 20.51% YoY), and the FY2025 full-year result was -$5.9 million, down 20.28% from the prior year.
• Free Cash Flow slipped to -$1.3 million in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$991131.0 in Q1 2024 to a low of -$2.3 million in Q1 2025.
• A 4-year average of -$1.5 million and a median of -$1.3 million in 2026 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow surged 45.3% in 2024 and tumbled 129.51% in 2025, its largest moves.
• Tracing MGRX's Free Cash Flow over 4 years: stood at -$1.7 million in 2023, then jumped by 33.47% to -$1.1 million in 2024, then grew by 4.59% to -$1.1 million in 2025, then fell by 21.67% to -$1.3 million in 2026.
• Business Quant data shows MGRX's Free Cash Flow at -$1.3 million in Q1 2026, -$1.1 million in Q4 2025, and -$1.2 million in Q3 2025.